Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.23+0.36 (+12.54%)
Close on Nov 16, 2026Market cap $265.01MP/E –Yield –
Lexeo Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Lexeo Therapeutics's operating margin for the twelve months ending Dec 31, 2022 was -9252.1%. For fiscal 2022 it was -9252.1%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -9252.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | -3292.3% | – |
See a number that looks wrong?